Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H5N1 Vaccine in Children 2-10 Years
NCT00402649Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Feb 2007
- Primary completion
- Oct 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Inactivated Influenza A/H5N1 Vaccine in influenza A virus H5N1 subtype infection (H5N1), sponsored by National Institute of Allergy and Infectious Diseases. Started Feb 2007; status: completed.
02
Drugs
Inactivated Influenza A/H5N1 Vaccine
03
Conditions
influenza A virus H5N1 subtype infection (H5N1)
Beyond the preview
Go deeper on NCT00402649.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00402649.